UNBELIEVABLE: Johnson johnson jnj - Caught on Camera

3 Blue-Chip Stocks with Strong Buy Ratings from Analysts

As a wave of volatility has been re-introduced to the system, investors are flocking toward blue-chip companies for stability and long-term growth potential. Thus, one could consider adding these three fundamentally sound blue-chip stocks, AbbVie (ABBV), Merck & Co. (MRK), and Johnson & Johnson (JNJ), with Strong Buy ratings from…

StockNews.com · Jan 8, 2025

3 Healthcare Stocks for Long-Term Stability and Growth

With the rise of chronic diseases, technological advances and innovative drug pipelines are driving significant growth in the healthcare industry. Hence, investors may find long-term stability and exciting opportunities by adding stocks, Johnson & Johnson (JNJ), Pfizer (PFE), and Cigna Group (CI), to their portfolios. Read more….

StockNews.com · Nov 6, 2024

3 Dividend Stocks With 3% or More Yields to Watch Now

Dividend stocks are a top choice for long-term investors, with dependable payout and steady performance. Therefore, it could be wise to keep track of top dividend stocks, such as Johnson & Johnson (JNJ), Northwest Natural Holding Co. (NWN), and Universal Corp (UVV). Read more….

StockNews.com · Oct 23, 2024

3 Pharma Stocks to Capitalize on With Potential Upside

The pharma industry’s prospects look bright, thanks to rising demand for innovative drugs. Thus, pharma stocks with potential upside, like GSK plc (GSK), Johnson & Johnson (JNJ), and Bristol-Myers Squibb Company (BMY), could be wise investments to capitalize on right now. Read on….

StockNews.com · Nov 2, 2023

3 Pharma Stocks on the Rise - Buy Now

The pharmaceutical industry is well-positioned for long-term growth thanks to rising investments in drug development and technological advancements. Thus, it would be prudent to buy pharma stocks, Sanofi (SNY), Johnson & Johnson (JNJ) and AstraZeneca PLC (AZN). Read on.

StockNews.com · Oct 26, 2023

Should You Invest in Johnson & Johnson (JNJ) Following Q3 Results

Johnson & Johnson’s (JNJ) third-quarter results impressed investors, as its earnings and revenue beat Wall Street estimates. Should investors consider investing in the stock following the solid third-quarter results? Read on to learn my view….

StockNews.com · Oct 24, 2023

Markets Today: Stocks Slip as Bond Yields Jump after U.S. Retail Sales Tops Forecasts

Morning Markets December E-Mini S&P 500 futures (ESZ2 3) are down -0.42%, and the Dec Nasdaq 100 E-Mini futures (NQZ2 3) are down -0.60%. Stock index futures this morning are moderately lower as the markets track diplomatic efforts to contain the Israel-Hamas conflict. Stock index futures extended their losses as...

Barchart · Oct 17, 2023

Which of these 3 Pharma Stocks Should You Buy, Hold or Sell?

The pharmaceutical industry is well-positioned for long-term growth thanks to rising investments in drug development and technological advancements. So, let's analyze whether Johnson & Johnson (JNJ), Calliditas Therapeutics AB (CALT), and Aurora Cannabis (ACB) are a Buy, Hold, or Sell.

StockNews.com · Sep 15, 2023

Is Johnson & Johnson (JNJ) a Buy Before September Begins?

Pharma giant Johnson & Johnson (JNJ) has posted robust second-quarter results and raised its full-year outlook. Should investors look into the stock before September begins? Let’s look at its financial metrics to gauge its prospects….

StockNews.com · Aug 28, 2023

3 Large Cap ETFs Investors Are Watching Everyday

Amidst market turbulence, large-cap ETFs tend to deliver stability and reliable cash flows while demonstrating less volatility. Hence, fundamentally strong large-cap ETFs Vanguard Value (VTV), Vanguard High Dividend Yield (VYM) and iShares Russell 1000 Value (IWD) might be solid additions to one’s watchlist. Continue reading.

StockNews.com · Aug 23, 2023